Login / Signup

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain.

Jeffrey Victor LazarusMarcela Villota-RivasPablo RyanMaria ButiLara Grau-LópezGuillermo CuevasJosé Luis EspadaWilliam MorónRaul Felipe Palma-ÁlvarezJordan J FeldJorge Valencia
Published in: Communications medicine (2023)
The intervention was accepted by 54 (62.8%) CAS participants and all MTU participants and can be used in marginalised communities.
Keyphrases
  • hepatitis c virus
  • randomized controlled trial
  • coronavirus disease
  • sars cov
  • crispr cas
  • human immunodeficiency virus
  • hiv infected